Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Steroid Adjunctive Treatment at Initiation of Avonex Therapy for Patients With Mono-Symptomatic or Relapsing-Remitting Multiple Sclerosis

NCT00232193 is registered in ClinicalTrials.gov with Providence Multiple Sclerosis Center as lead sponsor.

NCT NCT00232193
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00232193 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Steroid Adjunctive Treatment at Initiation of Avonex Therapy for Patients With Mono-Symptomatic or Relapsing-Remitting Multiple Sclerosis
Lead sponsor
Providence Multiple Sclerosis Center
Phase
Observational
Overall status
Completed
Start date
December 31, 2003
Completion date
August 31, 2010
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

clinically isolated syndrome, relapsing-remitting multiple sclerosis